Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Correction: Director Dealing and CLN Conversion

12 Nov 2020 07:00

RNS Number : 0361F
IQ-AI Limited
12 November 2020
 

IQ-AI Ltd

("IQ-AI" or the "Company")

Correction to Director Dealing and Conversion of Loan Notes Announcement

The following amendments have been made to the "Director Dealing and Conversion of Loan Notes" announcement released on 11 November at 07:00.

 

The original announcement stated that IQ-AI Ltd has received a conversion notice from Free Association Books Limited, converting £40,000 convertible loan notes and the £13,500 associated interest, into 3,566,666 Ordinary Shares. This should have been 3,566,667 Ordinary Shares. It also stated that Trevor Brown will be directly and indirectly interested in 47,557,403 Ordinary Shares, representing approximately 29.63 per cent. of the Company's enlarged issued ordinary share capital. This should have been 47,527,403 Ordinary Shares, representing approximately 29.61 per cent. of the Company's enlarged issued ordinary share capital.

All other details remain unchanged. The full amended text is shown below.

IQ-AI Ltd has received a conversion notice from Free Association Books Limited, converting £40,000 convertible loan notes and the £13,500 associated interest, issued in November 2015, at a price of 1.5 pence, into 3,566,667 Ordinary Shares. Free Association Books Limited ("FAB") is a company in which Trevor Brown, who is CEO of IQ-AI, has an interest. The Company has now fully converted all of the November 2020 convertible loan notes.

 

In addition, the Company has also received a conversion notice from Trevor Brown, converting £200,000 convertible loan notes and the £20,000 associated interest, issued in March 2018, at a price of 2 pence, into 11,000,000 Ordinary Shares.

 

In total, Trevor Brown will indirectly or directly be issued a total of 14,566,667 Ordinary Shares (the "CLN Shares"). In addition, Trevor Brown and FAB has in total sold 10,450,030 Ordinary Shares in the Company.

 

Following the above transactions, Trevor Brown will be directly and indirectly interested in 47,527,403 Ordinary Shares, representing approximately 29.61 per cent. of the Company's enlarged issued ordinary share capital. It is expected that the CLN Shares will commence trading on or around 17 November 2020 ("Admission").

 

Following Admission, the Company will have 160,522,649 ordinary shares of 0.01p each in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 160,522,649.

 

The above figure of 160,522,649 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

-ENDS-

For further information, please contact:

IQ-AI Limited

Trevor Brown/Vinod Kaushal/Qu Li

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Trevor Brown

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IQ-AI Ltd

b)

LEI

213800SPW48XRJS2QH57

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification code

Ordinary Shares of 1p eachISIN: JE00BD4H0R42

b)

Nature of the transaction

Sale of shares

c)

Price(s) and volume(s)

£0.17

75000

£0.15

75000

£0.15

75000

£0.14

1000000

£0.15

75000

£0.14

1000000

£0.11

1000000

£0.11

1000000

£0.15

1150030

£0.17

500000

 

 

d)

 

 

Aggregated information- Aggregated volume- Price

£0.11

4000000

 

 

N/A

e)

Date of the transaction

10 November 2020

f)

Place of the transaction

N/A

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Trevor Brown

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification /Amendment

Amendment to prior notifications

Late notification by selling broker

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IQ-AI Ltd

b)

LEI

213800SPW48XRJS2QH57

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification code

Ordinary Shares of 1p eachISIN: JE00BD4H0R42

b)

Nature of the transaction

Sale of shares

c)

Price(s) and volume(s)

500000 Ordinary Shares at a price of £0.12 per share

d)

Aggregated information- Aggregated volume- Price

N/A

e)

Date of the transaction

10 November 2020

f)

Place of the transaction

N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBBBFTMTJBBRM
Date   Source Headline
2nd Jan 201912:20 pmRNSHolding(s) in Company
13th Dec 20189:00 amRNSPrice Monitoring Extension
13th Dec 20187:00 amRNSStoneChecker 510k Update
11th Dec 20187:00 amRNSInstallation at Barrow Neurological Institute
28th Nov 20187:00 amRNSImaging Biometrics® Update
16th Nov 20187:00 amRNSFirst Commercial Sale of StoneChecker Software
22nd Oct 20187:00 amRNSIQ-AI files patent for Contrast-Free Imaging
4th Oct 20182:58 pmRNSResult of EGM and Change of Name
27th Sep 20187:00 amRNSIB announce agreement to develop a diagnostic tool
18th Sep 20187:00 amRNSProposed name change and notice of EGM
11th Sep 20189:00 amRNSDirector/PDMR Shareholding
11th Sep 20187:00 amRNSDirector/PDMR Shareholding
10th Sep 20187:00 amRNSHalf-year Report
6th Aug 20182:51 pmRNSHolding(s) in Company
6th Aug 20187:00 amRNSAppointment of CEO to the Operating Subsidiaries
1st Aug 20184:28 pmRNSPublication of a Prospectus
31st Jul 20183:54 pmRNSResult of AGM and GM
18th Jul 20181:24 pmRNSNon Regulatory - Vox Markets Podcast
18th Jul 20188:57 amRNSHolding(s) in Company
17th Jul 20187:00 amRNSECOG-ACRIN TO PROCESS CLINICAL TRIAL DATA USING IB
16th Jul 20187:00 amRNSPlacing, Notice of AGM and GM
2nd Jul 20188:34 amRNSMedimsight and IB Enter into Partnership
13th Jun 20187:00 amRNSImaging Biometrics and QMENTA announce partnership
9th May 20187:00 amRNSIB Software Chosen by St. Savvas Oncology Hospital
30th Apr 20184:25 pmRNSFinal Results
11th Apr 20187:00 amRNSIMAGING BIOMETRICS ANNOUNCES PARTNERSHIP
29th Mar 20182:52 pmRNSTotal Voting Rights
13th Mar 201810:54 amRNSTotal Voting Rights
13th Mar 20187:40 amRNSAcquisition of Imaging Biometrics
6th Mar 20187:00 amRNSStoneChecker signs agreement with Korea ISG
8th Feb 20181:44 pmRNSPotential Acquisition
8th Feb 20189:05 amRNSSecond Price Monitoring Extn
8th Feb 20189:00 amRNSPrice Monitoring Extension
11th Dec 20177:00 amRNSCE marked release of StoneChecker® Software
6th Nov 20174:40 pmRNSSecond Price Monitoring Extn
6th Nov 20174:35 pmRNSPrice Monitoring Extension
26th Oct 20177:00 amRNSUpdate on Business Operations
9th Oct 20172:33 pmRNSHolding(s) in Company
18th Sep 20177:00 amRNSUpdate on Product Development and Warrant Exercise
4th Sep 20179:49 amRNSStone Checker Update
30th Aug 201710:04 amRNSHolding(s) in Company
17th Aug 20177:01 amRNSDirector Dealings
17th Aug 20177:00 amRNSHalf-year Report
14th Aug 201710:12 amRNSHolding(s) in Company
27th Jul 20174:40 pmRNSSecond Price Monitoring Extn
27th Jul 20174:35 pmRNSPrice Monitoring Extension
11th Jul 20177:00 amRNSUpdate on Operations
3rd Jul 20177:00 amRNSConversion of Convertible Loan Notes into Equity
27th Jun 20174:40 pmRNSSecond Price Monitoring Extn
27th Jun 20174:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.